Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes

British Journal of Cancer

Volumn 109, Issue 5, 2013, Pages 1165-1171

  Kim, S I ^a   Cho, S H ^b   Lee, J S ^a   Moon, H G ^c   Noh, W C ^d   Youn, H J ^e   Ko, B K ^f   Park, B W ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Soongsil University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Korea Institute of Radiation and Medical Science   (South Korea)

^e Chonbuk National University Medical School   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

Author keywords

breast neoplasms; lymph node ratio; pN1; prognostic factor; predictive factor; post mastectomy radiation therapy

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; FEMALE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; OVERALL SURVIVAL; POSTMASTECTOMY RADIOTHERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE;

EID: 84883743524     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.465     Document Type: Article

References (42)

1. Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W (2007) Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea-a report from the Korean Breast Cancer Society. J Clin Oncol 25: 2360-2368. (Pubitemid 47007614)
2. Axelsson CK, Mouridsen HT, Zedeler K (1992) Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 28A: 1415-1418.
3. Carlson RW, Goldstein LJ, Gradishar WJ, Lichter AS, McCormick B, Moe RE, Theriault RL (1996) NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park) 10: 47-75.
4. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187. (Pubitemid 19032001)
5. Chagpar AB, Camp RL, Rimm DL (2011) Lymph node ratio should be considered for incorporation into staging for breast cancer. Ann Surg Oncol 18: 3143-3148.
6. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087-2106. (Pubitemid 41797643)
7. Danko ME, Bennett KM, Zhai J, Marks JR, Olson Jr. JA (2010) Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1 788 patients with long-term follow-up. J Am Coll Surg 210(797-805 e791): 805-797.
8. Edge SB. American Joint Committee on CancerAmerican Cancer Society (2010) AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. 7th (edn). Springer: New York.
9. Efron B (1979) Bootstrap methods: another look at the jackknife. Ann Stat 7: 1-26.
10. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347: 567-575.
11. Fisher ER, Costantino J, Fisher B, Redmond C (1993) Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators. Cancer 71: 2141-2150. (Pubitemid 23070681)
12. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966-978. (Pubitemid 30602038)
13. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20: 1319-1329.
14. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22: 1736-1747.
15. Katz A, Buchholz TA, Thames H, Smith CD, McNeese MD, Theriault R, Singletary SE, Strom EA (2001) Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys 50: 397-403. (Pubitemid 32472268)
16. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD (2000) Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18: 2817-2827. (Pubitemid 30623479)
17. Kim SI, Park BW, Lee KS (2006) Comparison of stage-specific outcome of breast cancer based on 5th and 6th AJCC staging system. J Surg Oncol 93: 221-227. (Pubitemid 43381995)
18. Kim SI, Park S, Park HS, Kim YB, Suh CO, Park BW (2011) Comparison of treatment outcome between breast-conservation surgery with radiation and total mastectomy without radiation in patients with one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 80: 1446-1452.
19. Kunkler IH, Canney P, van Tienhoven G, Russell NS. Mrc Eortc Supremo Trial Management Group (2008) Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol (R Coll Radiol) 20: 31-34.
20. Kuru B (2006) Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma. Eur J Surg Oncol 32: 1082-1088. (Pubitemid 44774399)
21. National Institutes of Health (1991) NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265: 391-395.
22. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J (2006) Loco-regional recurrence after mastectomy in high-risk breast cancer-risk and prognosis. An analysis of patients from the DBCG 82 b randomization trials. Radiother Oncol 79: 147-155. (Pubitemid 43867814)
23. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337: 949-955. (Pubitemid 27425950)
24. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353: 1641-1648. (Pubitemid 29224519)
25. Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b randomized trials. Radiother Oncol 82: 247-253. (Pubitemid 46350797)
26. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM, Paradis M, Coldman AJ, Olivotto IA (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337: 956-962. (Pubitemid 27425951)
27. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97: 116-126. (Pubitemid 40277091)
28. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge Jr GW, Whelan TJ, Pfister DG (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19: 1539-1569. (Pubitemid 32203717)
29. Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, Falkson G, Falkson HC, SGt Taylor, Tormey DC (1999) Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17: 1689-1700. (Pubitemid 29269237)
30. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20: 3628-3636. (Pubitemid 34983222)
31. Smith BD, Smith GL, Haffty BG (2005) Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol 23: 1409-1419.
32. Tausch C, Taucher S, Dubsky P, Seifert M, Reitsamer R, Kwasny W, Jakesz R, Fitzal F, Filipcic L, Fridrik M, Greil R, Gnant M (2012) Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG). Ann Surg Oncol 19: 1808-1817.
33. The Steering Committee (1998) The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ 158: S1-S2.
34. Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA (2005a) The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 103: 2006-2014. (Pubitemid 40605106)
35. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E (2005b) Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 61: 1337-1347. (Pubitemid 40470413)
36. Truong PT, Vinh-Hung V, Cserni G, Woodward WA, Tai P, Vlastos G (2008) The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic nodepositive breast cancer. Eur J Cancer 44: 1670-1677.
37. Vinh-Hung V, Burzykowski T, Cserni G, Voordeckers M, Van De Steene J, Storme G (2003a) Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol 22: 697-704.
38. Vinh-Hung V, Cserni G, Burzykowski T, van de Steene J, Voordeckers M, Storme G (2003b) Effect of the number of uninvolved nodes on survival in early breast cancer. Oncol Rep 10: 363-368.
39. Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, Deglise C, Usel M, Lutz JM, Bouchardy C (2009) Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 27: 1062-1068.
40. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G (2004) The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 70: 225-230. (Pubitemid 38520153)
41. Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA (2003) Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57: 336-344. (Pubitemid 37040928)
42. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, Vlastos G, Wallace AM, Hortobagyi GN, Nieto Y (2006) Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24: 2910-2916. (Pubitemid 46630594)